Content about Delayed Filing

February 25, 2013

Despite a wavering economy, all of the U.S. prestige beauty categories enjoyed healthy growth in 2012, according to global information company the NPD Group, which presented in late January the U.S. and global beauty industry's first look at 2012 year-end results for skin care, makeup and fragrance at its annual "Hot off the Press" event at the Harmonie Club in New York.

Despite a wavering economy, all of the U.S. prestige beauty categories enjoyed healthy growth in 2012, according to global information company the NPD Group, which presented in late January the U.S. and global beauty industry's first look at 2012 year-end results for skin care, makeup and fragrance at its annual "Hot off the Press" event at the Harmonie Club in New York.

Cosmetic Executive Women — a professional organization in the beauty, cosmetics, fragrance and related industries — partnered with the NPD Group to host this year's event.

July 31, 2012

Colgate-Palmolive announced in late July its second-quarter results and indicated that North American business remains solid, with market share on the rise in such categories as toothpaste and manual toothbrushes.

Colgate-Palmolive announced in late July its second-quarter results and indicated that North American business remains solid, with market share on the rise in such categories as toothpaste and manual toothbrushes.

November 29, 2010

A generic drug maker announced that the Food and Drug Administration has granted tentative approval for its version of a popular antidepressant.

MUMBAI, India — A generic drug maker announced that the Food and Drug Administration has granted tentative approval for its version of a popular antidepressant.

Sun Pharmaceutical Industries said the FDA approved its duloxetine hydrochloride delayed-release capsules in 20-mg, 30-mg and 60-mg strengths. The capsules are a generic version of Eli Lilly's Cymbalta, which is indicated to treat major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia and chronic musculoskeletal pain.